Cite

HARVARD Citation

    Ozyigit, G. et al. (n.d.). PO-0838 Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer. Radiotherapy and oncology. pp. S440-. [Online]. 
  
Back to record